The aims of this study were to 1) investigate whether elevated anti-TPO levels at diagnosis of GD lower the risk of relapse after ATD or RI treatment, and 2) determine whether elevated anti-TPO levels at diagnosis of GD increase the risk of developing hypothyroidism after ATD treatment. Here, TPO is linked to hypothyroidism.